Tufts Medical Center

tuftsmedicalcenter.org

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

195

Active

31

Phase 3

15

Total enrollment

102,015

Pipeline matrix

Showing 11 of 11 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Letermovir2
Vitamin D1
veverimer daily1
veverimer every other day1
tocilizumab2
Adalimumab2
Etanercept1
Upadacitinib1
Indocyanine green1
Vasopressor1
Inotrope1

Next readouts

  • 2025-12
  • 2025-12-15
  • 2026-01-01
  • 2027-12-15
  • 2028-03-01
  • 2030-03

Top conditions

  • Heart Failure7
  • Obesity6
  • Psoriasis6
  • Heart Diseases5
  • Chronic Kidney Disease5
  • Metabolic Syndrome4
  • Knee Osteoarthritis4
  • Lymphoma4

Frequently asked questions about Tufts Medical Center

How many clinical trials does Tufts Medical Center have on ClinicalTrials.gov?
Tufts Medical Center is listed as the lead sponsor on 195 clinical trials in ClinicalTrials.gov, 31 of which are currently active (recruiting, enrolling, or ongoing).
How many of Tufts Medical Center's trials are in Phase 3?
15 of Tufts Medical Center's trials are in Phase 3, spread across 11 active drug programs.
What therapeutic areas does Tufts Medical Center focus on?
Tufts Medical Center's most-studied conditions on ClinicalTrials.gov are Heart Failure, Obesity, Psoriasis, Heart Diseases, Chronic Kidney Disease.
When are Tufts Medical Center's next clinical trial readouts?
Tufts Medical Center has 6 upcoming primary-completion readouts tracked here; the soonest is “SLN Mapping and ICG Dye for Vulvar Cancer”, expected around 2025-12.